Backing Up QuickBooks Online: A Step-by-Step Guide
Data security is a top priority for QuickBooks to...
Synthetic Biology Market Dynamics: Transforming Healthcare, Agriculture, and Beyond
Meticulous Research®, a leading global market research company, has published a report titled "Synthetic Biology Market Size, Share, Forecast, & Trends Analysis by Product (Enzymes, Oligonucleotide, DNA), Technology (Gene Synthesis, Genome Editing, Sequencing, Cloning), Application (Life Sciences, Chemical, Food), End User – Global Forecast to 2031."Download Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5826
According to the report, the global synthetic biology market is projected to reach $80.20 billion by 2031, growing at a CAGR of 23.5% from 2024 to 2031. The market's growth is driven by several factors, including increased funding for synthetic biology research, declining sequencing costs, expanding applications of synthetic biology, advancements in gene engineering technologies, and rising research on synthetic vaccines. However, concerns regarding biosafety, biosecurity, and ethical issues related to synthetic biology may hinder market growth.
Opportunities for growth are expected to arise from increasing R&D funding, a growing focus on personalized medicine, and innovations in synthetic biology. However, challenges such as the potential impact of synthetic organisms on ecosystems and public hesitation in accepting synthetic biology technologies may impede market progress.
Key Players
Major players in the global synthetic biology market include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Novozymes A/S (Denmark), Codexis, Inc. (U.S.), Creative Biogene Inc. (U.S.), Amyris, Inc. (U.S.), Precigen, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs (U.S.), Ginkgo Bioworks (U.S.), Genscript Biotech Corp. (U.S.), Eurofins Scientific SE (France), and Twist Bioscience (U.S.).
Browse In Depth: https://www.meticulousresearch.com/product/synthetic-biology-market-5826
Synthetic Biology Market: Future Outlook
The synthetic biology market is segmented by Product (Oligonucleotide and Synthetic DNA, Xeno-Nucleic Acids, Enzymes, Cloning Technologies Kits, Chassis Organism, Other Products), Technology (Gene Synthesis, Sequencing, Genome Editing, Cloning, Site-Directed Mutagenesis, Bioinformatics, and Other Technologies), Application (Life Science & Healthcare, Industrial & Chemical, Food & Agriculture, and Environmental), End Users (Pharmaceutical, Biotechnology, & MedTech Companies, CMOs & CROs, Academic & Research Institutes, Food & Agriculture Industry, Chemical Industry, Environmental Agencies, and Other End Users), and Geography. The report also provides a comprehensive analysis of industry competitors and evaluates the market at global and regional levels.
- By Product: In 2024, the oligonucleotide and synthetic DNA segment is expected to account for the largest share of the synthetic biology market. Synthetic oligonucleotides are widely used in the development of novel therapeutics and the manufacturing of commodity chemicals, perfumes, and textiles. The expanding applications of synthetic DNA and oligonucleotides across various industries, including environmental biotechnology, are driving this segment's growth. Their use in designing entities capable of degrading pollutants, creating biofuels, and mitigating environmental contaminants further supports their dominance.
- By Technology: The gene synthesis segment is expected to hold the largest market share in 2024. Gene synthesis technology simplifies the creation of mutated, recombinant, or novel DNA sequences without a template, which would otherwise be a tedious task with traditional methods. This technology is vital in areas such as protein engineering, pathway design, genome engineering, plant biology, oncology, structural biology, neurosciences, and synthetic vaccines, contributing to its leading position in the market.
- By Application: The life science & healthcare application is projected to account for the largest share of the synthetic biology market in 2024. The segment's dominance is driven by the increasing focus on synthetic vaccines, the need to develop novel therapies, rising drug discovery initiatives, and government investments in drug R&D. For instance, in July 2022, the Council of Scientific and Industrial Research (CSIR) in India invested $6.73 million in drug discovery and development, underscoring the growing demand for synthetic biology tools in drug research.
- By End User: Pharmaceutical, biotechnology, and MedTech companies are expected to be the largest end users of synthetic biology in 2024. This segment's growth is fueled by the increasing number of research laboratories, higher investments in R&D, and rising funding for pharmaceutical research. The growing demand for new drugs and therapies is driving investments in research, further boosting the demand for synthetic biology tools. For example, NIH funding increased from $42 billion in 2021 to $45 billion in 2022 for research purposes (Source: Congressional Research Service).
Quick Buy – Synthetic Biology Market – Global Opportunity Analysis and Industry Forecast (2024-2031), Research Report: https://www.meticulousresearch.com/Checkout/89564550
Regional Insights
The report provides an in-depth analysis of the market across major geographies, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to register the highest growth rate during the forecast period. Factors such as increasing research on synthetic vaccines, rising demand for fuel alternatives, supportive policies for biofuel production, growing pharmaceutical R&D expenditure, and advancements in biotechnology are driving market growth in this region. For instance, the Indian government has established the Department of Biotechnology (DBT) and other government-funded institutions like the National Biotechnology Board (NBTB) to position India as a global hub for biotech research and business excellence. India’s bioeconomy was valued at $137 billion in 2023 and is projected to reach $150 billion by 2025 (Source: India Brand Equity Foundation). The advancements in biotechnology are expected to increase the demand for synthetic biology tools for applications such as synthetic vaccines, biofuels, biopeptides, and more.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Please login to comment on this Post